On this site you can find recent news about Profil. You can read more about Profil and our work as clinical research organization. Furthermore, we will discuss interesting topics that are of high interest to pharmaceutical or technology companies innovating in the diabetes field.
For any questions or comments, please feel free to contact us using the contact button on the right.
October 1, 2019
Type 1 diabetes is a T-cell mediated autoimmune disease. For more than 40 years, researchers have tried to intervene in the autoimmune process to halt or perhaps even reverse the slow destruction of
September 17, 2019
Waiving Bridging studies under certain circumstances for biosimilar applications? A bridging study is a study performed in a new region to provide pharmacodynamic or clinical data on efficacy,
September 3, 2019
Treatment inertia calls for an integrated personalized diabetes management: iPDM Diabetes represents a huge and multidimensional challenge for European societes. It not only leads to premature ageing
August 21, 2019
Introduction The euglycemic, hyperinsulinemic glucose clamp is the gold standard for the determination of pharmacokinetic and pharmacodynamic (PK/PD) effects of new anti-diabetic drugs, in particular
July 23, 2019
Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.
July 16, 2019
Dual-hormone artificial pancreas systems use insulin and glucagon to control glucose in patients with diabetes - a dream is about to come true Insulin-only closed-loop AP systems hold promise for
July 2, 2019
Dear all, It is my great honour and pride to present the Profil Science Report 2018. Altogether, Profil’s scientific experts published 29 scientific publications (cumulated impact factor of > 150)
June 18, 2019
The impact of different study populations in glucose clamp studies Over the last decade, the euglycemic clamp technique has evolved to the reference method for assessing time action profiles of